The investigators intend to test in a single center, clinical pilot efficacy study the primary hypothesis that Magnetic Seizure Therapy (MST) as add-on therapy to a controlled pharmacotherapy is efficacious in the treatment of refractory major depression assessed with the Hamilton Depression Rating Scale (HAMD).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
30
Right unilateral placement, 3x seizure threshold, 3 times per week for 4 weeks
100% power, vertex placement, 3 times per week for 4 weeks
Department of Psychiatry and Psychotherapy - University Hospital
Bonn, Germany
Clinical improvement (Hamilton Rating Scale for Depression)
Time frame: After each treatment and at followups up to 3 months after the treatment course
Clinical improvement (Montgomery- Åsberg Rating Scale for Depression)
Time frame: After each treatment and at followups up to 3 months after the treatment course
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.